Levomepromazine for nausea and vomiting in advanced cancer

Hosp Med. 1999 Aug;60(8):568-70. doi: 10.12968/hosp.1999.60.8.1176.

Abstract

Levomepromazine (previously known as methotrimeprazine), despite virtually no high quality scientific data to support its use, has become a very popular antiemetic for use in patients with advanced cancer. This article considers the reasons for this.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dopamine Antagonists / adverse effects
  • Dopamine Antagonists / therapeutic use*
  • Humans
  • Methotrimeprazine / adverse effects
  • Methotrimeprazine / therapeutic use*
  • Nausea / drug therapy*
  • Nausea / etiology
  • Neoplasms / complications*
  • Palliative Care
  • Vomiting / drug therapy*
  • Vomiting / etiology

Substances

  • Dopamine Antagonists
  • Methotrimeprazine